Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Akebia Therapeutics, Inc. | akbaex321.htm |
| EX-31.2 - EX-31.2 - Akebia Therapeutics, Inc. | akbaex312.htm |
| EX-31.1 - EX-31.1 - Akebia Therapeutics, Inc. | akbaex311.htm |
| EX-23.1 - EX-23.1 - Akebia Therapeutics, Inc. | exhibit231-eyconsent.htm |
| EX-10.59 - EX-10.59 - Akebia Therapeutics, Inc. | exhibit1059d-finalredacted.htm |
| EX-10.58 - EX-10.58 - Akebia Therapeutics, Inc. | exhibit105eryxxsiegfriedms.htm |
| EX-10.57 - EX-10.57 - Akebia Therapeutics, Inc. | exhibit1057-keryxxsiegfrie.htm |
| EX-10.19 - EX-10.19 - Akebia Therapeutics, Inc. | exhibit1019-directorcomppr.htm |
| EX-10.8 - EX-10.8 - Akebia Therapeutics, Inc. | exhibit108-sixthamendmentt.htm |
| EX-4.6 - EX-4.6 - Akebia Therapeutics, Inc. | exhibit46b-descriptionofth.htm |
| 10-K - 10-K - Akebia Therapeutics, Inc. | akba-20201231.htm |
Exhibit 21.1
SUBSIDIARIES OF THE REGISTRANT
| Name | Jurisdiction of Organization | ||||
| Akebia Therapeutics Securities Corporation | Massachusetts | ||||
| Akebia Europe Limited | Ireland | ||||
| Keryx Biopharmaceuticals, Inc. | Delaware | ||||
| ACCESS Oncology, Inc. | Delaware | ||||
| AOI Pharma, Inc. | Delaware | ||||
| AOI Pharmaceuticals, Inc. | Delaware | ||||
| Online Collaborative Oncology Group, Inc. | Delaware | ||||
| Accumin Diagnostics, Inc. | Delaware | ||||
| Neryx Biopharmaceuticals, Inc. | Delaware | ||||
| Keryx Biopharma UK Ltd. | United Kingdom | ||||